businessfortnight

India has reported the highest rate of coronavirus recoveries in the world, which has crossed the 80 per cent-mark, said Union Health Ministry today. Addressing the Health Ministry press briefing on the COVID-19 situation, Rajesh Bhushan, Secretary, Union Health Ministry said, “We get swayed by the narrative that India has over 50 lakh cases, but we forget that nearly 45 lakh people have already recovered. India has the highest recoveries, 44.9 lakh in the world. India contributes 17.7 per cent share in the total COVID-19 cases (globally). However, in terms of recovered cases, India shares 19.5 per cent of the total recovered cases (globally).” Mr Bhushan further stated that India’s recovery rate is over 80 per cent. Over one lakh recoveries have been registered in the last 24 hours. “We have conducted 6.5 crore tests while 12 lakh tests were conducted on a single day.” “One of the major reasons for these developments is that India was able to detect coronavirus before, isolate early a

India has achieved record recoveries of 1,01,468 COVID-19 patients in the last 24 hours, the Health Ministry data shows. Its coronavirus tally crossed the 55-lakh mark with a spike of 75,083 cases and 1,053 deaths. This is the fourth day when the number of daily recoveries is higher than the daily cases. With almost 45 lakh people (44,97,868) having beaten COVID-19 since the beginning of the pandemic, the overall recovery rate has increased to 80.86 per cent. The active cases in the 24-hour period reduced to 9,75,861, these account for 17.54 per cent of all cases. India has, so far, recorded 55, 62,664 COVID-19 cases, the Health Ministry data shows. A total of 88,935 people have lost their lives to COVID-19 till now. The country’s fatality rate stands at 1.59 per cent. Positivity rate in the country stands at 8.02 per cent as 9,33,185 tests were conducted in the last 24 hours, Health Ministry data shows. In September alone, India has recorded 19,41,238 lakh new coronavirus cases with 1

India’s COVID-19 tally reached 54.88 lakh with 86,961 people being infected in the past 24 hours, while 43,96,399 people have recuperated so far pushing the national recovery rate to 80.12 per cent on Sunday, according to the Union Health Ministry data. The total coronavirus cases mounted to 54,87,580, while the death toll climbed to 87,882 with the infection claiming 1,130 lives in a span of 24 hours in the country, the data updated at 8 am showed. The COVID-19 case fatality rate due to coronavirus has further declined to 1.6 per cent. There are 10,03,299 active cases in the country as of now, which comprises 18.28 per cent of the total caseload, the data stated. According to the Indian Council of Medical Research (ICMR), a cumulative total of 6,43,92,594 samples have been tested up to September 20, with 7,31,534 samples being tested on Monday.

With 83,809 new infections reported in the last 24 hours, India's coronavirus tally has crossed the 49 lakh mark. The pandemic claimed 1,054 lives in the last 24 hours taking India's total death count past the 80,000 mark. The country now has 9.90 lakh active cases and a total 38.59 lakh patients in the country have recovered from COVID-19. Maharashtra remains the worst affected state by the pandemic, followed by Andhra Pradesh, Tamil Nadu and Karnataka and Uttar Pradesh. Worldwide, almost 3 crore people have been infected by Sars-CoV-2, and more than 9.23 lakh people have lost their lives to the pandemic since it surfaced in China late last year.

Drug firm Indoco Remedies on Monday said it has received approval from the US health regulator for blood thinning drug Apixaban tablets. The approved product is therapeutically equivalent to the reference listed drug Eliquis of Bristol-Myers Squibb. In a regulatory filing, Indoco Remedies said it has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Apixaban tablets in the strengths of 2.5 mg and 5 mg. Apixaban is an anticoagulant, or blood thinner. It is used for patients with health problems caused by a blood clot. Quoting IMS June 2020 moving annual total data, Indoco Remedies said the US market size of Apixaban tablets is USD 11,037 million. Shares of Indoco Remedies were trading 3.50 per cent higher at Rs 228.95 apiece on BSE.

New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said. The Drugs Controller General Of India (DCGI) has also directed the Serum Institute of India (SII) to increase the safety monitoring of the subjects who have already been vaccinated as part of the trial and submit the plan and report. On Thursday, the Serum Institute, headed by Adar Poonawalla, said it would pause Phase 3 trials that were to begin in India next week after AstraZeneca stopped vaccine trials across four nations as a precautionary measure. The pausing of trials by the pharma giant was linked to a UK volunteer showing potentially adverse symptoms. “We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials,” read a statement from the Serum Institute, which was

Delhi Lt Governor Anil Baijal on Wednesday directed officers to augment the city's testing capacity by taking a few steps, including 'testing on demand', testing at the national capital's border points and at major construction sites to check the spread of COVID-19. Sources said that during a meeting of Delhi Disaster Management Authority, the lieutenant governor asked officers to prepare detailed SOPs to introduce such testing facilities in the city. They said that a helpline number will soon be launched, where a person, who has COVID-19 symptoms, can book testing and thereafter, can avail the facility at his or her doorstep. “In first phase, senior citizens, women and children are likely to avail 'testing on demand' facility. Another option is that people can also book testing at nearby centres by making a call at the helpline number,” a source told PTI. The LG has asked officers to set up testing facilities at Delhi's border points as well for the screen

Parents should be “reassured” Covid-19 has not caused the deaths of any otherwise healthy schoolchildren in the UK, researchers say. Children's risk of needing hospital treatment for coronavirus is “tiny” and critical care “even tinier”, they say. However, black children, those who are obese and very young babies have a slightly higher risk. The BMJ study looked at 651 children with coronavirus in hospitals in England, Wales and Scotland. It covers two-thirds of all children's admissions in the UK due to Covid-19 between January and July and confirms what is already known about the minimal effects of the virus on children. A “strikingly low” 1% of these 651 children and young people – six in total – had died in hospital with Covid-19 compared with 27% across all other age groups, the study found. Eighteen per cent of the children needed intensive care. And the six who had died had had “profound” underlying health conditions that had often been complex and themselves life-limiti

One of India's leading health & wellness companies, Butterfly Ayurveda, recently launched Coronafly, an Ayurvedic medicine for the management of COVID-19. Amid the Coronavirus scare in the world, people are looking up to alternative and traditional medicines along with modern medical science. Managing an infectious disease like Coronavirus is a big challenge in any field of healthcare. Ayurveda, the ancient medical science of life, has answers for effective management of Coronavirus symptoms. The viral infection attacks human immunity in its first attempt. However, just like a wildfire, the communal spread of the virus is fast. People are taking stringent measures to stay protected and keep their immunity strong. The increase in production and sale of health supplements, and body shielding accessories like masks and gloves is just part of this domino effect. Although these are effective steps, they are not sufficient. Something like a viral pandemic demands more protection. T

While the retail sector is currently witnessing a slowdown amid COVID with regards to newer brand announcements, Grafdoer takes a leap forward by introducing Multipurpose Disinfectant spray under its new Health & Wellness brand ‘Edhini’ New Delhi: Sanitizers and Disinfectant Sprays have become a pivotal part of our lives, owing to the ongoing pandemic situation. Adjusting to the new normal and getting back to regular activities, one thing that will become essential for every individual to carry will be Disinfectant spray. Analysing the scenario, Grafdoer under its Health & Wellness Brand ‘ Edhini’ introduced Multipurpose Disinfectant Spray available in 300ml container, made from natural ingredients. Edhini ’s Disinfectant spray assures purifying your place and destroying the germs (99.9%) which although present is invisible to bare eyes. An effective Germ killer this spray is not only suitable for soft surfaces and hard surfaces like tables, doorknobs, keys, packages etc. bu

A provisional patent for the novel DNA aptamer and saliva Covid-19 test kit has been lodged Codenamed “Gumnuts”, the test is extremely low cost, convenient and easy to use, significantly cheaper than current RNA and antigen-based test kits A world-class international team of scientist has been assembled for development and commercialisation Clinical trials will commence shortly, with a view to commercial availability before the end of 2020 August 2020 – Achiko AG (SIX:ACHI, ISIN CH0522213468) is pleased to announce progress with a non-intrusive and affordable novel Covid-19 test kit, codenamed “Gumnuts”. With the assistance from Australian intellectual property firm FB Rice (Melbourne), developer Regenacellx.sl (“RCX”) has filed a provisional patent over the technology. Achiko holds the exclusive commercialisation rights in exchange for a royalty and technical advice. The Company has assembled a world-class internationally recognised team for the development and commercialisation of G

Currently, 1 in 1000 individuals globally and possibly, more than 10,000 individuals in Bangalore suffer from a problem in their immune system and are unable to fight infections in a normal way The book aims to strengthen the capacity of every Pediatrician and physician and help them diagnose these children early Bangalore, August, 2020: While everyone in the healthcare industry is currently focused on how to cure COVID -19 or find its vaccine, instances of primary immunodeficiency diseases are currently going unchecked and under-diagnosed. The current pandemic has now more than ever made it crucial for stakeholders in the healthcare industry to invest in the understanding of Immunology as many children continue to suffer immune deficiencies and are possibly, at an increased risk of developing severe COVID illness. Keeping this in the view, Aster CMI Hospital, a leading healthcare provider in the country has launched a book, authored by Dr. Sagar Bhattad, Consultant – Paediatric Imm

Mumbai, August 2020 : Graphitto Labs, one of the India’s fastest growing heath care start-up based in Mumbai is betting big to offer innovative & newer technologies in the health-care sector in the country. In the recent months, the health care start-up has launched unique range of Protective equipment including Face Masks, PPE Kits, Oximeters etc amongst others. With the honourable Prime Minister’s call for Aatma Nirbhar Bharat, Graphitto Labs is focussed on creating products under Vocal for Local schemes and is planning to set up a state of the art research & innovation lab in the state of Maharashtra. The company has recently launched a new face mask accessory – “Masky” an ear protector band, that helps relieve the stress caused on your ears while wearing face masks. It intends to make wearing face masks comfortable for a longer duration. Graphitto Labs has access to over 1000+retail outlets and over a million customers online. The company has offices in Mumbai and Delhi and

Increase in awareness and acceptance of personalized medicines to drive the growth of global therapeutic drug monitoring market According to TechSci Research , “ Global Therapeutic Drug Monitoring Market By Technology( Immunoassays, Proteomic Technologies ), By Drug Class(Antiarrhythmic Drugs, Immunosuppressants, Antiepileptic Drugs, Others ), By Active Ingredient (Amikacin, Caffeine, Carbamazepine, Cyclosporine, Digitoxin, Digoxin, Disopyramide, Ethosuxamide, Gentamicin, Lidocaine, Lithium, Methotrexate, NAPA, Phenobarbital, Quinidine, Sirolimus, Tacrolimus, Vancomycin, Others), By End-User (Hospitals, Diagnostic Centres, Others), By Product (Immunoassay Equipment, Reagents, Other Consumables), By Region, Forecast & Opportunities, 2025 ” , the global therapeutic drug monitoring market is expected to grow at a steady CAGR rate during the forecast period on account of growing demand for genetic testing. It’s a practice of measuring drug amount in bloodstream to maintain its eff

Hyderabad, August, 2020….Rotary Club of Secunderabad Sunrise embarks on a novel and need of the hour project, ‘COVID Care For The Elders’ as a gratitude and concern for the elderly. The project was formally flagged of today by President of the club Vijay Rathi long with the District Governor, NV Hanmantha Reddy and Rotarian Kamal Jain, Assistant Governor of Rotary District 3150 As part of this project, the club distributed symbolically in a brief and small function held at Somajiguda to Home for the Aged, Musheerabad the Medical Equipment and Medicines to help Home for the Aged fight against the COVID -19 battle. Sister Kathleen and Sister Josephine from Home for the Aged, Musheerabad received the much needed relief in care of elders. The distribution kits include Oxygen Concentrators, Oximeters, BP Machines, Nebulizers, contactless sanitizer dispensers and assorted medicines among others. A vehicle with these supplies was flagged and the same has gone to all the 40 Homes to hand

The liver is an important organ in the body with a critical role. One of the largest organs in the body and located in the upper portion of the abdomen, it is vital for detoxification. Blood travels through the digestive tract into the liver, where it is metabolized and toxins are filtered. One of the most common ailments that affect the liver is Hepatitis. This World Hepatitis Day let us understand the various types of Hepatitis and how to prevent the infection. Hepatitis is a group of disorders that causes liver inflammation. According to the World Health Organization (WHO), about 100 million people worldwide are suffering from Hepatitis which is undiagnosed. This is because specifically two forms, i.e. Hepatitis B and C damage the liver slowly over a period of time without any symptoms. It is for this reason that Hepatitis has been given the moniker of ‘the silent killer’. Hepatitis is categorized into 5 main types – Hepatitis A, B, C, D and E. Hepatitis A and E: These two forms of

With a leaping 14,40,371 positive Coronaviru s cases in India and the Covid-19 curve steadily going upwards every day, it is time for us to focus on the aspect of the community spread of this virus. Although there has been no official record of community transmission yet, it is essential for us to be aware of it, how it can take place and the ways of preventing it. As otherwise, the impact of community spread in a country like India with the world's largest population could be extremely adverse and uncontrollable. What is Community Transmission? While we have spent considerable time in complete nationwide lockdown and followed advisories and are now living in the phase of a relaxed lockdown with a stringent lockdown in only the widely affected areas, we are not yet in terms of community transmission. It refers to the condition when the virus gets transmitted without anyone knowing the definite source of infection. In cases of highly transmissive diseases like Covid-19, one may con

The invention of ventilators has saved the lives of numerous patients, suffering from respiratory failure-a medical emergency characterized by low oxygen and high carbon-dioxide levels in the body due to the inability to breathe appropriately as compared to a normal healthy person. ‘SwasthVayu’ is the first “Made in India” non-invasive ventilator being developed by the National Aerospace Laboratories (NAL), Bengaluru in scientific and medical knowledge collaboration with Dr Satyanarayana Mysore HOD, Pulmonology Respiratory & Sleep Medicine, Lung Transplant Physician at Manipal Hospitals, Bengaluru and Dr Anurag Agarwal, Director of Council of Scientific and Industrial Research (CSIR) – Institute of Genomics and Integrative Biology (IGIB). At the beginning of the pandemic, foreseeing the large outbreak of COVID 19 cases in India, there was a clarion call by the Honorable Prime Minister to all the entrepreneurs and scientists, to innovate and ramp up health care systems, includ

New Delhi, July 21, 2020 – Leading Indian health technology organization Trivitron Healthcare enters into collaboration with Anatomage Inc, a market leader in 3D medical virtualization technology, to distribute Virtual Anatomy Dissection Table for Medical education for scholars, researchers, medical & healthcare students in South and West Regions in India. Anatomage Virtual Anatomy Dissection Table offers strategic advantage when it comes to medical education and anatomical studies offering advanced and unique anatomy content to users for educational and training purposes. The Anatomage Table is the only fully segmented real human 3D anatomy system. Users can visualize anatomy exactly as they would on a fresh cadaver. Individual structures are reconstructed in accurate 3D, resulting in an unprecedented level of real accurate anatomy, dissectible in 3D. The Table allows for exploration and learning of human anatomy beyond what any cadaver could offer. Now that the world embraces for

Contributed by Col Binu Sharma, Senior Vice President- Nursing Services, Columbia Asia Hospitals We are living in unprecedented times, as we have to step up our efforts to provide the most optimum, safe care to our patients during the global COVID-19 crisis. This year is significantly shining a light on the contribution of nurses to healthcare delivery, health systems and community. Around the world it has been a vital task more than ever to boost health care workforce capacity and further enhancement of the role of nurses and paramedic workers has never been more crucial. With the world suffering the burden of COVID 19 pandemic, upskilling the nurses and paramedic workers has been the paramount aspect of health care delivery systems. The upskilling training programs are intended to balance community, patients and self-safety with the need to enable governments hospitals and nurses to do what is needed to respond to COVID-19. Upskill training programs are designed to prepare nurses to